BRAF and cancer: Focusing on cancer-associated SNVs, we demonstrate that even within the seed region, Cas12a-based SNV detection is not specific per se, but that crRNA engineering of the seed region can yield high-fidelity detection of BRAF p.V600E on synthetic target oligonucleotides, cell culture-derived material, and liquid biopsy material.